News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
ICR launches new website to showcase its world-class research

16/07/14

The Institute of Cancer Research, London, today launches a sophisticated new website designed to use news and multimedia to provide the public with a window onto its world-leading cancer research.
Darwinian evolution: from dinosaurs to cancer drug resistance

15/07/14

Birds evolving from dinosaurs, fish emerging from the sea, and hominids adopting an upright posture – all are iconic examples of evolution. On the surface they don’t have a great deal to do with cancer, but the process underlying them both — natural selection — is identical.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
Signal may send cancer’s cellular factories into overdrive

09/07/14

A network of signals active in almost all types of cancer sends the protein factories in our cells into overdrive, and may help fuel a tumour’s uncontrolled growth, Chelsea scientists have found.
ICR Logo
ICR awards ceremony celebrates achievements of new cancer research graduates

02/07/14

Students, public figures and academics were honoured during the annual awards ceremony for graduates of The Institute of Cancer Research, London.
Cells on a microscope slide
Tuberculosis protein helps spot breast cancer’s signals

01/07/14

Scientists have used a protein from Mycobacterium tuberculosis – the bacterium that causes most cases of tuberculosis – to unravel the signals produced by cancer from those of healthy cells.
Dr Chiara Braconi
ICR researcher shortlisted for prestigious L’Oréal-UNESCO Fellowship for Women in Science

13/06/14

Dr Chiara Braconi of the Division of Cancer Therapeutics at the ICR has been shortlisted for a prestigious award for women in science for her work on pancreatic cancer.
ICR Logo
New clues to skin cancer development show sunscreen is not enough

11/06/14

Scientists have shown that sunscreen cannot be relied upon alone to prevent malignant melanoma, the most deadly form of skin cancer.
Drug Discovery
ICR tops rankings for invention income earned from its research

11/06/14

A new analysis ranks the ICR first among UK higher education institutions for income from intellectual property in figures adjusted for size.
ICR Logo
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment

05/06/14

High-tech radiotherapy, drug combinations, and immunotherapy are showcased as future of cancer treatment at Cheltenham Science Festival
Uwe Oelfke
New technology to allow simultaneous tumour imaging and radiotherapy treatment

05/06/14

The ICR has entered into a pioneering research collaboration with manufacturer Elekta which aims to develop a state-of-the-art radiotherapy system.
ICR commits to openness on animal research

03/06/14

The Concordat on Openness on Animal Research will ensure members of the public have access to accurate information about when, how and why animals are used in research.
ICR Logo
Smokers with gene defect have one in four chance of developing lung cancer

01/06/14

Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.